Wide Media Coverage May Signal Your Stock Has Peaked
Posted in General Email This Post No comments yet
Usually, when a stock you own gets good press, it often translates into profits. Nobody wants to miss “the next big thing,” and that can fuel buying interest in an issue. Interestingly, Investor Business Daily’s Scott Stoddard suggests in his piece “Wide Media Coverage May Signal Your Stock Has Peaked,” that too much media coverage [...]
I’m Putting Real Money on This Spin-Off
Posted in Stock Picks Email This Post No comments yet
Jim Royal is a regular contributor to the Motley Fool, specializing in writing about “special situations”—identifying stocks that he believes should rise in price for very specific reasons. Last month, in a piece titled “I’m Putting Real Money on This Spin-Off,” he wrote about a recent spin-off from Valero (VLO) called CST Brands (CST), which [...]
Before the month of May ends, stock analysts everywhere are taking up the old adage, “sell in May and Go Away,” and putting their own spin on it. Last week we presented an article on the market’s historical performance in May, which didn’t support the adage. Today, Jonas Elmerrajii takes a look at a basket [...]
One of the most common ways investors evaluate a company is to compare its stock performance and valuation to other companies in the same sector. A look at relative sales, earnings and growth rates often can lead to the identification of an issue that has the potential to trade higher, or conversely, might make a [...]
When you have an important decision to make in your life, do you ask just one person for advice? If you’re like most folks, the answer is no. You probably ask three people… four… even ten. So why should your portfolio be any different? The short answer is it shouldn’t. I fully believe that, and [...]
Upcoming Catalysts Could Push ChemoCentryx to Double In 2013
Posted in Stock Picks Email This Post No comments yet
Traders are always on the lookout for stocks that have strong growth potential, dubbing the “potential 10-baggers,” or “potential doublers.” After all, who wouldn’t want to double their investment money, or better still, get back 1,000% returns? In a lengthy and detailed piece for SeekingAlpha titled, “Upcoming Catalysts Could Push ChemoCentryx to Double in 2013,” [...]
By any measure, U.S. stock markets have been on an extraordinary run this year. While it’s hard to resist the temptation to ride the bull run higher, there will be a time when the markets fall—and historically, spring has been one of those times. For that reason, Motley Fool blogger Robert Ciura raises the question, [...]
A Key Sell Sign: A Weak Rebound After A Big Sell-Off
Posted in General Email This Post No comments yet
Most traders spend the majority of their time looking for issues that appear poised to break higher, in pursuit of quick gains. Far less time, however, is usually dedicated to drawing up a game plan as to when it’s the best time to lock in profits. In an ongoing Investor’s Business Daily column called Investor’s [...]
Like people, stocks go through good times and bad. And, like people, sometimes when something bad happens to a stock it tends to overshadow all the good things. In her recent Barron’s piece “Baxter Can Bounce Back,” author Dimitra Defotis profiles the shares of pharma heavyweight Baxter International (BAX), making a bull case for the [...]
5 Dividend Stocks Ready to Give You a Raise
Posted in Stock Picks Email This Post No comments yet
Although dividend-paying stocks aren’t in vogue with the fast-money crowd, they’ve always had a strong following among institutional investors and funds looking to lock in gains on less risky, dividend-generating issues In his Stockpikr.com piece “5 Dividend Stocks Ready to Give You a Raise,” Jonas Elmerraji talks about the current value of owning dividend-paying stocks, [...]



